ebook img

Melancholia: The diagnosis, pathophysiology, and treatment of depressive illness PDF

561 Pages·2006·2.483 MB·English
Save to my drive
Quick download
Download
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Melancholia: The diagnosis, pathophysiology, and treatment of depressive illness

Melancholia This book provides a comprehensive review of melancholia as a severe disorder of mood, associated with suicide, psychosis, and catatonia. The syndrome is defined with a clear diagnosis, prognosis, and range of management strategies, diVerentiated from other similar psychiatric, neurological, and general medical conditions. It challenges accepted doctrines in the classification and biology of the mood disorders and defines melancholia as a treatable mental illness. Described for millennia in medical texts and used as a term in literature and poetry, melancholiawas included within early versions of the major diagnostic classification systems, but lost favor in later editions. This book updates the arguments for the diagnosis, describesitscharacteristicsindetail,andpromotestreatmentandprevention.ThebookoVers greathopetothosewithadisordertoooftenmisdiagnosedandoftenfatal.Itshouldbereadby allthoseresponsibleforthemanagementofpatientswithmooddisorders. Michael Alan Taylor is Professor of Psychiatry Emeritus at Rosalind Franklin University of MedicineandScience,NorthChicago,ILandAdjunctClinicalProfessorofPsychiatryatthe UniversityofMichiganSchoolofMedicine,AnnArbor,MI,USA. Max Fink is Professor of Psychiatry and Neurology Emeritus at the State University of New YorkatStonyBrook,USA. Melancholia The diagnosis, pathophysiology, and treatment of depressive illness Michael Alan Taylor, M.D. ProfessorofPsychiatryEmeritusatRosalindFranklin UniversityofMedicineandScience,NorthChicago,IL, andAdjunctClinicalProfessorofPsychiatryatthe UniversityofMichiganSchoolofMedicine, AnnArbor,MI,USA Max Fink, M.D. ProfessorofPsychiatryandNeurologyEmeritus, StateUniversityofNewYorkatStonyBrook,USA CAMBRIDGEUNIVERSITY PRESS Cambridge, New York, Melbourne, Madrid, Cape Town, Singapore, São Paulo Cambridge University Press The Edinburgh Building, Cambridge CB28RU, UK Published in the United States of America by Cambridge University Press, New York www.cambridge.org Information on this title: www.cambridge.org/9780521841511 © M. A. Taylor and M. Fink 2006 This publication is in copyright. Subject to statutory exception and to the provision of relevant collective licensing agreements, no reproduction of any part may take place without the written permission of Cambridge University Press. First published in print format 2006 ISBN-13 978-0-511-22105-7 eBook (NetLibrary) ISBN-10 0-511-22105-3 eBook (NetLibrary) ISBN-13 978-0-521-84151-1 hardback ISBN-10 0-521-84151-8 hardback Cambridge University Press has no responsibility for the persistence or accuracy of urls for external or third-party internet websites referred to in this publication, and does not guarantee that any content on such websites is, or will remain, accurate or appropriate. Contents List of patient vignettes page ix Preface xi Acknowledgments xv 1 Melancholia: a conceptual histor y 1 Origins of the concept 2 The psychodynamic interruption 6 The recognition ofmelancholia in psychiatricclassification 7 Notes 10 2 Melancholia defined 15 Melancholy 15 Manic-depressiveillness 18 Psychoticdepressionis melancholia 24 Depressionwith catatoniaor stupor is severemelancholia 30 Melancholiadefined bya specificevent 32 Notes 37 3 Defining melancholia by psychopatholog y 45 DSMdepressioncategories anddiagnosticcriteria 46 Consensus and empirical approaches defining a syndrome 51 Psychopathologydata supporting the validityof melancholia 53 The natureofmelancholia 56 Conclusions 58 Notes 59 4 Defining melancholia: laborator y tests 62 Neuroendocrine measuresin mood disorders 62 The hypothalamic–pituitary–adrenal axis 64 The hypothalamic–pituitary–thyroid axis 72 Electrophysiologicmeasures 72 v vi Contents Conclusions 76 Notes 78 5 Examination for melancholia 85 Examination strategy 86 Examining mood 87 Examining psychomotor functioning 88 Examining for vegetativesigns 88 Examining for psychotic features 89 Examining for suicidal thoughts 90 Examining cognition 90 Examining for personalitydisorder 91 Rating scales of depression 91 Notes 95 6 The di Verential diag nosis of melancholia 97 Non-melancholicdepressivemood disorders 97 Melancholia in childrenandadolescents 103 Melancholia in theelderly 104 Melancholia in a patient with a psychoticdisorder 106 Distinguishing melancholiafrom anxiety and obsessive-compulsivedisorders 108 Distinguishing melancholiafrom drug-related depressive-likestates 109 Melancholia associated with general medical illnesses 110 Avolitional, apathetic, and bradykinetic syndromes 112 Neurologicdisease associated with apathyand depression-likesyndromes 113 Notes 118 7 Suicide in melancholia 125 Errorsin suicide prevention 126 Suiciderisk assessment 134 The eV ect of specific treatments onsuiciderates 139 Management of thesuicidal melancholic patient 143 Notes 146 8 Electroconv ulsive therapy for melancholia 153 ECTin melancholia 155 ECT for psychoticdepression 157 ECTandsuiciderisk 159 ECT forcatatonia and depressivestupor 161 ECTin pregnancy andpostpartum depression 163 ECTin childrenand adolescents 165 ECTin the elderly 170 ECTandcharacterological conditions 171 vii Contents ECTin unipolar andbipolardepression 172 Conclusion 174 Notes 174 9 Achiev ing e Vective ECT 181 Patient selection 181 Technical considerations 183 Conclusions 190 Notes 190 10 The validity of the phar macotherapy literature in melancholia 196 Industry influenceundermines conclusions about newer agents 197 Head-to-head comparisons arebiased tofavornewerdrugs 199 Antidepressantdrug eY cacy: TCAversuspureSSRI 201 Antidepressantdrug eY cacy: pureSSRIscompared tonon-TCAagents 204 Conclusions 206 Notes 207 11 Basic phar macotherapy for melancholic patients 211 Acute treatment 212 Combiningdrugs and psychotherapy 218 Continuation and maintenancetreatment 219 Pharmacotherapy formelancholia 220 Treatmentof severemelancholia 222 Optimizing treatments for manic-depressiveillness 229 Notes 231 12 Phar macotherapy for melancholic patients in complicating circumstances 239 Melancholiain pregnancy andbreast-feeding 239 Melancholiain childhood and adolescence 244 Melancholiain old age 250 Melancholiawith co-occurring alcoholordrug abuse 255 Melancholiawith co-occurring neurologicdisease 257 Melancholiaco-occurring with general medical conditions 261 Melancholiawith co-occurring personalitydisorder 265 Summary recommendations 266 Treatment-resistant depression 268 Notes 273 13 Proposed treatments for melancholia 284 Lighttherapy 284 Transcranial magneticstimulation 286 Magnetic seizuretherapy (MST) 288 Vagal nerve stimulation(VNS) 289 viii Contents Glucocorticosteroid receptoragonists 289 Targetedneurotransmitter system agents 290 Hormones 291 Herbal remedies 292 Notes 294 14 The pathophysiolog y of melancholia 298 Geneticpredisposition 299 Environmental factors 303 Abnormal stressresponse 307 Abnormal neurochemical functioning 311 Abnormal brain structure 317 Abnormal brain metabolism 318 Electrophysiologic abnormalities 320 Cognitivedeficits 327 Why some melancholic patientshavemanicepisodes 328 Conclusions 330 Notes 333 15 Future directions 346 Changing theDSMclassification ofdepression 347 Changing theDSMdiagnosticcriteria formelancholia 348 Changing thestandardsof pharmacotherapy research 349 Changing treatment guidelines: endlessdrug trials elicit chronicity 351 Improving theeducation of medical practitioners in mood disorders 351 Studies ofthe mechanismof convulsivetherapy 353 Preventiveapproaches toreduce theburdenof melancholia 354 Pharmacogenetics 359 The pathophysiologyof melancholia 360 Coda 364 Notes 365 References 371 Index 522 Patient vignettes 2.1 Awomanwith melancholia (Hopewell-Ash) page 17 2.2 Awomanwith melancholia (Hopewell-Ash) 17 2.3 A manwith melancholia (Hopewell-Ash) 17 2.4 Awomanwith melancholia (Hopewell-Ash) 17 2.5 Awomanwith cycloid psychosis(Hopewell-Ash) 22 2.6 A manwith a psychoticmelancholia (DSM-IVCasebook) 28 2.7 A manwith psychotic melancholia(Fink) 28 2.8 Awomanwith Cotardsyndrome (HansenandBolwig) 29 2.9 Awomanwith melancholia (Taylor) 30 2.10 Acatatonic womanwith psychoticmelancholia (Kalhbaum) 31 2.11 A 15-year-old girlwith psychotic melancholiaand catatonia (Hoch) 32 2.12 Awomanwith a postpartum melancholia (Protheroe) 35 2.13 Awomanwith postpartummelancholia (Hamilton) 35 3.1 A manwith an apathetic frontal lobe syndrome meeting criteriafor major depression (Vaidyaand Taylor) 49 5.1 A melancholic manwith a psychoticdepression (Taylor) 89 6.1 An epileptic manwith brief depressions (Taylor) 116 7.1 An 87-year-old womanwith apsychoticdepression(Taylor) 128 7.2 A 44-year-old melancholic man misdiagnosed with PTSD who committed suicide (Taylor) 130 7.3 A hospitalized depressedwomanwith asuicideplan (Taylor) 131 7.4 A melancholic womanwho receivedpoor treatment (Taylor) 132 7.5 A 30-year-old manwith a ‘‘postpartum’’melancholia (Taylor) 133 7.6 A manwho refused hospitalization and committed suicide (Taylor) 133 7.7 A 70-year-old manwho hanged himself(Taylor) 137 7.8 A 21-year-old womanwhomadea suicide attemptfollowinga psychodynamic interview (Taylor) 145 8.1 A 66-year-old womanwith melancholia (Fink) 157 8.2 Aprofessorof surgerydescribes his psychoticdepression(Nuland) 158 8.3 A former medical schooldean describes his depression (Rosenberg) 160 8.4 A 58-year-old womanwith melancholia and catatonia misdiagnosed as having Alzheimer’sdisease (Fink) 162 ix

See more

The list of books you might like

Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.